Equity Overview
Price & Market Data
Price: $0.0₅1
Daily Change: -$0.0₄99 / 9,900%
Daily Range: $0.0₅1 - $0.0₅1
Market Cap: $1,473
Daily Volume: 700
Performance Metrics
1 Week: -99.00%
1 Month: -99.00%
3 Months: -99.90%
6 Months: -99.90%
1 Year: -99.80%
YTD: %
Details
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is based in Port Moody, Canada.